A Lifeline for Rare Diseases
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
With high rates of diabetes across the country and nearly 38% of adults having prediabetes, UPMC Health Plan is committed to reducing the incidence of diabetes in its community as part of the ACHP Chronic Disease Pledge.
UPMC Health Plan is focusing its Chronic Disease Pledge commitments on reducing the incidence of diabetes in its population through an innovative behavioral health coaching program.
ACHP President and CEO Ceci Connolly coauthored an op-ed examining if the obesity epidemic could be solved with free GLP-1s.
ACHP member HealthPartners has outlined strategies to reduce hypertension in its community as part of the Chronic Disease Pledge.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.